PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Pharmaceutical Biology and Phytochemistry, University of Münster, Münster, Germany.\', \'Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.\', \'Pharmacognosy and Phytotherapy, UCL School of Pharmacy, London, UK.\', \'Technical Biochemistry, TU Dortmund University, Dortmund, Germany.\', \'Institute of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Münster, Münster, Germany.\', \'University Medicine Rostock, Chair of Complementary Medicine, Rostock, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1055/a-1177-4396
?:doi
?:hasPublicationType
?:journal
  • Planta medica
is ?:pmid of
?:pmid
?:pmid
  • 32434254
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.581
?:rankingScore_hIndex
  • 100
is ?:relation_isRelatedTo_publication of
?:title
  • Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32434254>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32434254>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all